Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SS 0331

Next Previous
Drug Profile

SS 0331

Alternative Names: nebulised SS0331; SIS; SoftOx Inhaled Solution; SS-0331

Latest Information Update: 16 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SoftOx Solutions
  • Class Anti-infectives; Anti-inflammatories; Chlorine compounds; Eye disorder therapies; Noncarboxylic acids; Oxides; Reactive oxygen species; Skin disorder therapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Respiration disorders

Most Recent Events

  • 02 Mar 2026 SoftOx Solutions plans a phase I trial for Respiratory-tract-infections (In Volunteers) in Ireland (Inhalation) (CTIS2025-523530-30-00)
  • 19 Dec 2025 Phase-I/II clinical trials in Respiration disorders in Denmark (Inhalation)
  • 13 Apr 2022 SoftOx Solutions completes phase-I clinical trials in Respiration disorders (In volunteers) in Denmark (Inhalation) (NCT05188638)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top